AZN
Astrazeneca Plc Earnings
$68.2
Earnings Summary
Revenue | $13565Mn |
Net Profits | $1429Mn |
Net Profit Margins | 10.53% |
Astrazeneca Plc’s revenue jumped 18.04% since last year same period to $13565Mn in the Q3 2024. On a quarterly growth basis, Astrazeneca Plc has generated 4.85% jump in its revenue since last 3-months.
Astrazeneca Plc’s net profit jumped 4% since last year same period to $1429Mn in the Q3 2024. On a quarterly growth basis, Astrazeneca Plc has generated -25.84% fall in its net profits since last 3-months.
Astrazeneca Plc’s net profit margin fell -11.89% since last year same period to 10.53% in the Q3 2024. On a quarterly growth basis, Astrazeneca Plc has generated -29.27% fall in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the Astrazeneca Plc post its latest quarter earningsEPS Estimate Current Quarter | 1.04 |
EPS Estimate Current Year | 1.04 |
Astrazeneca Plc’s earning per share (EPS) estimates for the current quarter stand at 1.04 - a -13.33% fall from last quarter’s estimates.
Astrazeneca Plc’s earning per share (EPS) estimates for the current year stand at 1.04.
Key Ratios
Key ratios of the Astrazeneca Plc post its Q3 2024 earningsEarning Per Share (EPS) | 0.46 |
Dividend Per Share (DPS) | 0.5 |
Astrazeneca Plc’s earning per share (EPS) fell -47.43% since last year same period to 0.46 in the Q3 2024. This indicates that the Astrazeneca Plc has generated -47.43% annual rate of fall in its earning per share (EPS) in the last 4 quarters.
Astrazeneca Plc declared 0.5 dividend per share during the earnings announcement for Q3 2024.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2024-03-31 | 1.22 | 1.03 | -15.57% |
2024-06-30 | 1.2 | 0.99 | -17.5% |
2024-09-30 | 1.04 | 0.46 | -56.02% |
₹0 US Stocks a/c Opening Fee